A phase 2, multicenter, open label, randomized trial of AMG 706 [motesanib] or bevacizumab in combination with paclitaxel and carboplatin for advanced non-squamous non-small cell lung cancer.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 08 Jan 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

13 Aug 2012 Actual end date (1 Aug 2011) added as reported by ClincialTrials.gov.
25 Aug 2011 New source identified and integrated (Clinical Trial Registry - India; CTRI2007-091-000017).
01 Aug 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com